Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; without any observations. The inspection was carried out from 6th January, 2020 to 8th January, 2020.
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.553.6 as compared to the previous close of Rs. 556.45. The total number of shares traded during the day was 1386 in over 227 trades.
The stock hit an intraday high of Rs. 564.65 and intraday low of 549.45. The net turnover during the day was Rs. 767164.